Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study in healthy adults evaluating cabotegravir (GSK1265744) with rilpivirine and dolutegravir; study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Viral Hepatitis

Drugs mentioned

• Dolutegravir (dolutegravir)
• cabotegravir (cabotegravir)
• rilpivirine (rilpivirine)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infections, Human Immunodeficiency Virus and Hepatitis | Phase 1 | Status: COMPLETED